147 related articles for article (PubMed ID: 22699881)
1. Association between genetic variants in glutathione peroxidase 1 gene and risk of prostate cancer: a meta-analysis.
Liwei L; Wei Z; Ruifa H; Chunyu L
Mol Biol Rep; 2012 Sep; 39(9):8615-9. PubMed ID: 22699881
[TBL] [Abstract][Full Text] [Related]
2. The rs1050450 C > T polymorphism of GPX1 is associated with the risk of bladder but not prostate cancer: evidence from a meta-analysis.
Men T; Zhang X; Yang J; Shen B; Li X; Chen D; Wang J
Tumour Biol; 2014 Jan; 35(1):269-75. PubMed ID: 23975365
[TBL] [Abstract][Full Text] [Related]
3. GPX1 gene Pro200Leu polymorphism, erythrocyte GPX activity, and cancer risk.
Hong Z; Tian C; Zhang X
Mol Biol Rep; 2013 Feb; 40(2):1801-12. PubMed ID: 23073788
[TBL] [Abstract][Full Text] [Related]
4. Glutathione peroxidase 1 (GPX1) genetic polymorphism, erythrocyte GPX activity, and prostate cancer risk.
Arsova-Sarafinovska Z; Matevska N; Eken A; Petrovski D; Banev S; Dzikova S; Georgiev V; Sikole A; Erdem O; Sayal A; Aydin A; Dimovski AJ
Int Urol Nephrol; 2009; 41(1):63-70. PubMed ID: 18563616
[TBL] [Abstract][Full Text] [Related]
5. Association of GPX1 polymorphism, GPX activity and prostate cancer risk.
Erdem O; Eken A; Akay C; Arsova-Sarafinovska Z; Matevska N; Suturkova L; Erten K; Özgök Y; Dimovski A; Sayal A; Aydin A
Hum Exp Toxicol; 2012 Jan; 31(1):24-31. PubMed ID: 21636625
[TBL] [Abstract][Full Text] [Related]
6. GPX1 Pro198Leu polymorphism and breast cancer risk: a meta-analysis.
Hu J; Zhou GW; Wang N; Wang YJ
Breast Cancer Res Treat; 2010 Nov; 124(2):425-31. PubMed ID: 20306294
[TBL] [Abstract][Full Text] [Related]
7. Association between fibroblast growth factor receptor-4 gene polymorphism and risk of prostate cancer: a meta-analysis.
Liwei L; Chunyu L; Jie L; Ruifa H
Urol Int; 2011; 87(2):159-64. PubMed ID: 21625079
[TBL] [Abstract][Full Text] [Related]
8. Association between genetic variants in glutathione peroxidase 1 (GPx1) gene, GPx activity and the risk of prostate cancer.
Kucukgergin C; Gokpinar M; Sanli O; Tefik T; Oktar T; Seckin S
Minerva Urol Nefrol; 2011 Sep; 63(3):183-90. PubMed ID: 21993316
[TBL] [Abstract][Full Text] [Related]
9. Single-nucleotide polymorphisms of GPX1 and MnSOD and susceptibility to bladder cancer: a systematic review and meta-analysis.
Cao M; Mu X; Jiang C; Yang G; Chen H; Xue W
Tumour Biol; 2014 Jan; 35(1):759-64. PubMed ID: 24037914
[TBL] [Abstract][Full Text] [Related]
10. Association between GPX1 Pro189Leu polymorphism and the occurrence of bladder cancer in Morocco.
Hadami K; Ameziane El Hassani R; Ameur A; Dakka N; Abbar M; Al Bouzidi A; Attaleb M; El Mzibri M
Cell Mol Biol (Noisy-le-grand); 2016 Dec; 62(14):38-43. PubMed ID: 28145855
[TBL] [Abstract][Full Text] [Related]
11. Analysis of manganese superoxide dismutase (MnSOD Ala-9Val) and glutathione peroxidase (GPx1 Pro 198 Leu) gene polymorphisms in psoriasis.
Kalkan G; Seçkin HY; Baş Y; Benli I; Ozyurt H; Ateş O; Ozdemir A; Pancar GS
Arch Dermatol Res; 2014 Apr; 306(3):253-8. PubMed ID: 24212762
[TBL] [Abstract][Full Text] [Related]
12. Association between glutathione peroxidase 1 codon 198 variant and the occurrence of breast cancer in Rwanda.
Habyarimana T; Bakri Y; Mugenzi P; Mazarati JB; Attaleb M; El Mzibri M
Mol Genet Genomic Med; 2018 Mar; 6(2):268-275. PubMed ID: 29411539
[TBL] [Abstract][Full Text] [Related]
13. Pro198Leu polymorphism in the oxidative stress gene, glutathione peroxidase-1, is associated with a gender-specific risk for panic disorder.
Cengiz M; Bayoglu B; Alansal NO; Cengiz S; Dirican A; Kocabasoglu N
Int J Psychiatry Clin Pract; 2015; 19(3):201-7. PubMed ID: 25666858
[TBL] [Abstract][Full Text] [Related]
14. GPx-1 polymorphism (rs1050450) contributes to tumor susceptibility: evidence from meta-analysis.
Chen J; Cao Q; Qin C; Shao P; Wu Y; Wang M; Zhang Z; Yin C
J Cancer Res Clin Oncol; 2011 Oct; 137(10):1553-61. PubMed ID: 21842217
[TBL] [Abstract][Full Text] [Related]
15. Association between the GCG polymorphism of the selenium dependent GPX1 gene and the risk of young onset prostate cancer.
Kote-Jarai Z; Durocher F; Edwards SM; Hamoudi R; Jackson RA; Ardern-Jones A; Murkin A; Dearnaley DP; Kirby R; Houlston R; Easton DF; Eeles R;
Prostate Cancer Prostatic Dis; 2002; 5(3):189-92. PubMed ID: 12496980
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of glutathione peroxidase 1 (GPX1 Pro198Leu) and catalase (CAT C-262T) in women with spontaneous abortion.
Sabet EE; Salehi Z; Khodayari S; Zarafshan SS; Zahiri Z
Syst Biol Reprod Med; 2014 Oct; 60(5):304-7. PubMed ID: 25033027
[TBL] [Abstract][Full Text] [Related]
17. Association between Polymorphisms of Antioxidant Gene (MnSOD, CAT, and GPx1) and Risk of Coronary Artery Disease.
Yeh HL; Kuo LT; Sung FC; Yeh CC
Biomed Res Int; 2018; 2018():5086869. PubMed ID: 30225256
[TBL] [Abstract][Full Text] [Related]
18. Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study.
Ravn-Haren G; Olsen A; Tjønneland A; Dragsted LO; Nexø BA; Wallin H; Overvad K; Raaschou-Nielsen O; Vogel U
Carcinogenesis; 2006 Apr; 27(4):820-5. PubMed ID: 16287877
[TBL] [Abstract][Full Text] [Related]
19. No association between GPX1 Pro198Leu and breast cancer risk.
Cox DG; Hankinson SE; Kraft P; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1821-2. PubMed ID: 15533915
[No Abstract] [Full Text] [Related]
20. Plasma antioxidants, genetic variation in SOD2, CAT, GPX1, GPX4, and prostate cancer survival.
Van Blarigan EL; Ma J; Kenfield SA; Stampfer MJ; Sesso HD; Giovannucci EL; Witte JS; Erdman JW; Chan JM; Penney KL
Cancer Epidemiol Biomarkers Prev; 2014 Jun; 23(6):1037-46. PubMed ID: 24711484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
